3-hydroxy-3-methylglutaryl-CoA synthase deficiency: genes and variants
Explore variant evidence for 3-hydroxy-3-methylglutaryl-CoA synthase deficiency across 1 analyzed protein (HMGCS2). Linked ClinVar records include 19 pathogenic or likely pathogenic variants, 86 variants of uncertain significance and 10 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-11-04. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to 3-hydroxy-3-methylglutaryl-CoA synthase deficiency
HMGCS2: Hydroxymethylglutaryl-CoA synthase, mitochondrial
It catalyzes the rate-limiting mitochondrial step of ketone-body synthesis, allowing the liver to convert fatty-acid-derived acetyl-CoA into ketones during fasting. Biallelic deficiency causes impaired ketogenesis with fasting hypoglycemia and potentially severe metabolic decompensation.
19 ClinVar pathogenic / likely pathogenic and 96 uncertain variants in HMGCS2 have source records linked to 3-hydroxy-3-methylglutaryl-CoA synthase deficiency. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to 3-hydroxy-3-methylglutaryl-CoA synthase deficiency
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| HMGCS2 R501P | 501 | Pathogenic / likely pathogenic (★★) | |
| HMGCS2 G388R | 388 | Pathogenic / likely pathogenic (★★) | |
| HMGCS2 R501Q | 501 | Pathogenic / likely pathogenic (★★) | |
| HMGCS2 G212R | 212 | Pathogenic / likely pathogenic (★★) | |
| HMGCS2 R500H | 500 | Pathogenic / likely pathogenic (★★) | |
| HMGCS2 F174L | 174 | Pathogenic / likely pathogenic (★★) | |
| HMGCS2 V54M | 54 | Pathogenic / likely pathogenic (★★) | |
| HMGCS2 F364I | 364 | Pathogenic / likely pathogenic (★★) | |
| HMGCS2 D240A | 240 | Pathogenic / likely pathogenic (★) | |
| HMGCS2 D240V | 240 | Pathogenic / likely pathogenic (★) | |
| HMGCS2 D136G | 136 | Pathogenic / likely pathogenic (★) | |
| HMGCS2 G219E | 219 | Pathogenic / likely pathogenic (★) | |
| HMGCS2 G55D | 55 | Pathogenic / likely pathogenic (★) | |
| HMGCS2 E74K | 74 | Pathogenic / likely pathogenic (★) | |
| HMGCS2 V141D | 141 | Pathogenic / likely pathogenic (★) | |
| HMGCS2 A171V | 171 | Pathogenic / likely pathogenic (★) | |
| HMGCS2 V253A | 253 | Pathogenic / likely pathogenic (★) | |
| HMGCS2 T302I | 302 | Pathogenic / likely pathogenic (★) | |
| HMGCS2 Y167C | 167 | Pathogenic / likely pathogenic |
Uncertain variants prioritized for review in 3-hydroxy-3-methylglutaryl-CoA synthase deficiency
| Variant | Position | Protein part | Clinical label | Evidence |
|---|---|---|---|---|
| HMGCS2 R500C | 500 | Conflicting reports (★) | +6: 3 other pathogenic changes within 3 positions; R500H at the same position is pathogenic; REVEL 0.818 |
Frequently asked questions
Which genes have records linked to 3-hydroxy-3-methylglutaryl-CoA synthase deficiency?
This view contains 1 analyzed proteins: HMGCS2. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 19 pathogenic or likely pathogenic variants, 86 variants of uncertain significance and 10 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 1 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 130 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center